Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

Presentation

Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible ACS

December 14, 2017

Presentation TCT 2017

Flash Debate: If Anything, Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should be Downgraded Based on EXCEL and NOBLE!

Presenter: Sanjay Kaul, Tullio Palmerini, Jacek Legutko

November 01, 2017

Presentation TCT 2017

Flash Debate: Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should Be Upgraded to Class I Based on EXCEL and NOBLE!

Presenter: Sanjay Kaul, Tullio Palmerini, Evald H. Christiansen

November 01, 2017

Presentation TCT 2017

Case #1 Introduction: Low-Risk 65-Year-Old Patient With Severe Aortic Stenosis Refuses Surgical TAVR Because They Want TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

The NOTION 2 Low-risk Trial in Younger Patients

Presenter: Lars Sondergaard

October 30, 2017

Presentation TCT 2017

The Evolut R Low-risk Trial

Presenter: Jeffrey J. Popma

October 30, 2017

Presentation TCT 2017

The PARTNER 3 Low-risk Trial

Presenter: Michael J. Mack

October 30, 2017

Presentation TCT 2017

Viewpoint #2: Not So Fast! GARY and Other Studies Indicate an Important Role for Surgery in Intermediate-risk Patients

Presenter: Thomas Walther

October 30, 2017

Presentation TCT 2017

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

Presenter: Michael J. Reardon

October 30, 2017

Presentation TCT 2017

MitraClip For the Low and Intermediate Risk Degenerative MR Patient: Ethics and Outcomes

Presenter: Ted Feldman, Scott Lim, James B. Hermiller Jr.

October 30, 2017

Presentation TCT 2017

Case Presentation: Mitraclip in a Low to Intermediate Surgical Risk Patient With Degenerative MR

Presenter: Ted Feldman, Scott Lim, Michael J. Rinaldi

October 30, 2017

Presentation TCT 2017

Conclusions and Take-home Messages

Presenter: Dariusz Dudek, Martin Hudec

October 30, 2017

Presentation TCT 2017

Germany Presents: Case Conclusion - How I Treated This Case

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Presentation TCT 2017

Slovakia Comments: How Would I Treat This Case?

Presenter: Dariusz Dudek, Martin Hudec, Branislav Liska

October 30, 2017

Presentation TCT 2017

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Presentation TCT 2017

Czech Republic Presents: Case Conclusion - How I Treated This Case

Presenter: Dariusz Dudek, Martin Hudec, Marian Branny

October 30, 2017

Presentation TCT 2017

Poland Comments: How Would I Treat This Case?

Presenter: Dariusz Dudek, Martin Hudec, Wojtek Wojakowski

October 30, 2017

Presentation TCT 2017

Czech Republic Presents: Case Introduction - Severe Aortic Stenosis in a Low-Risk Patient

Presenter: Dariusz Dudek, Martin Hudec, Marian Branny

October 30, 2017

Presentation TCT 2017

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Presenter: Dariusz Dudek, Martin Hudec, Michael Haude

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Craig R. Smith

October 30, 2017

Advertisement

Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible ACS

Flash Debate: If Anything, Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should be Downgraded Based on EXCEL and NOBLE!

Flash Debate: Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should Be Upgraded to Class I Based on EXCEL and NOBLE!

Case #1 Introduction: Low-Risk 65-Year-Old Patient With Severe Aortic Stenosis Refuses Surgical TAVR Because They Want TAVR

The NOTION 2 Low-risk Trial in Younger Patients

The Evolut R Low-risk Trial

The PARTNER 3 Low-risk Trial

Viewpoint #2: Not So Fast! GARY and Other Studies Indicate an Important Role for Surgery in Intermediate-risk Patients

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

MitraClip For the Low and Intermediate Risk Degenerative MR Patient: Ethics and Outcomes

Case Presentation: Mitraclip in a Low to Intermediate Surgical Risk Patient With Degenerative MR

Conclusions and Take-home Messages

Germany Presents: Case Conclusion - How I Treated This Case

Slovakia Comments: How Would I Treat This Case?

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Czech Republic Presents: Case Conclusion - How I Treated This Case

Poland Comments: How Would I Treat This Case?

Czech Republic Presents: Case Introduction - Severe Aortic Stenosis in a Low-Risk Patient

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content